You’ve probably heard the story of Henrietta Lacks’ cells, which spawned more than 17,000 patents, a bestselling book and a made-for-TV movie starring Oprah. The cancer cells were harvested from Lacks’ cervix without her consent in 1951. According to Johns Hopkins, where doctors took the cells, the resulting “immortal” cell line, known as HeLa, has contributed to medical breakthroughs

Quick Read

What began as a tete-a-tete about a community tennis center is now poised to potentially reshape how we think about who owns our DNA and the information it encodes.

Quick Read

Dr. Jeffrey Kahn, director of the Berman Institute, raises some cautions. “There’s kind of a range of issues that people need to think about before they swab their cheek and send their credit card,”. Kahn said that besides the potential of unearthing long-buried family secrets, there’s the issue of what happens to the data. Many consumers don’t realize that if they agree to all the terms, their information is likely sold

Quick Read

And don’t seem to care that we don’t know who officially owns CRISPR. A Swiss startup hoping to harness the gene-editing technology it’s named after to develop treatments for genetic illnesses like sickle-cell anemia and cystic fibrosis—went public today (Oct. 19), raising $56 million in its initial public offering

Quick Read

Alleged theft from Italian gene bank dismissed — but ownership of samples remains under investigation

Quick Read

One person’s biohazard is another person’s baby blues elixir

Quick Read

President Obama remarked “I would like to think that if somebody does a test on me or my genes, that that’s mine.” Lots of people would make that same assumption – it seems sensible that we would each “own” our genetic information. But the legal reality is quite different

Quick Read

dversaries in the legal battle over the rights to the CRISPR gene-editing technology are preparing to fire their initial shots. In two documents filed with the U.S. Patent Trial and Appeal Board last week, lawyers for the Regents of the University of California (UC) and the Broad Institute (BI) in Cambridge, Massachusetts, offered hints at how they will lay claim to the breakthrough technology and its financial spoils

Quick Read